3

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: March 1, 2017
Period of Report: March 1, 2017
Accession Number: 0001019056-17-000258

View Document ↗ View on SEC.gov ↗